Immunological mechanisms of epidermal damage in toxic epidermal necrolysis

被引:28
作者
Tohyama, Mikiko [1 ]
Hashimoto, Koji [1 ]
机构
[1] Ehime Univ, Dept Dermatol, Grad Sch Med, Toon City, Ehime 7910295, Japan
关键词
apoptosis-inducing factor; cytotoxic lymphocyte; macrophage; monocyte; toxic epidermal necrolysis; STEVENS-JOHNSON-SYNDROME; REGULATORY T-CELLS; SOLUBLE FAS LIGAND; EFFECTOR-CELLS; GRANULYSIN; EXPRESSION; 4-1BB; APOPTOSIS; ALPHA; CYCLOSPORINE;
D O I
10.1097/ACI.0b013e328355b865
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Purpose of review The purpose of the present review is to introduce recent findings on the pathomechanisms of toxic epidermal necrolysis (TEN), which is characterized by widespread epidermal detachment due to keratinocyte apoptosis. Recent findings In the mechanism of epidermal damage, the roles of drug metabolites, cytotoxic lymphocytes, and apoptosis-inducing factors have been noted. In addition, recent studies have focused on monocytes/macrophages, which may participate in epidermal damage through the production of apoptosis-inducing factors and the expression of costimulatory factors with the ability to activate CD8(+) T cells. Summary Epidermal keratinocyte death is a hallmark of TEN. In a very high proportion of cases, drugs are responsible for TEN. It has been suggested that toxic drug metabolites produced by keratinocytes act like electrophilic agents to induce apoptosis and inflammation. Next, cytotoxic lymphocytes and monocytes function in the development of widespread epidermal damage through direct or indirect cytotoxic pathways. In addition, T-cell activation may be strengthened by the impairment of regulatory T-cell function and activated monocytes. The development of epidermal damage in TEN may require the coordinated action of these factors.
引用
收藏
页码:376 / 382
页数:7
相关论文
共 66 条
[51]   4-1BB costimulatory signals preferentially induce CD8(+) T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses [J].
Shuford, WW ;
Klussman, K ;
Tritchler, DD ;
Loo, DT ;
Chalupny, J ;
Siadak, AW ;
Brown, TJ ;
Emswiler, J ;
Raecho, H ;
Larsen, CP ;
Pearson, TC ;
Ledbetter, JA ;
Aruffo, A ;
Mittler, RS .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (01) :47-55
[52]   Preparations of intravenous immunoglobulins diminish the number and proinflammatory response of CD14+CD16++ monocytes in common variable immunodeficiency (CVID) patients [J].
Siedlar, Maciej ;
Strach, Magdalena ;
Bukowska-Strakova, Karolina ;
Lenart, Marzena ;
Szaflarska, Anna ;
Weglarczyk, Kazimierz ;
Rutkowska, Magdalena ;
Baj-Krzyworzeka, Monika ;
Pituch-Noworolska, Anna ;
Kowalczyk, Danuta ;
Grodzicki, Tomasz ;
Ziegler-Heitbrock, Loems ;
Zembala, Marek .
CLINICAL IMMUNOLOGY, 2011, 139 (02) :122-132
[53]   Soluble FAS ligand: A discriminating feature between drug-induced skin eruptions and viral exanthemas [J].
Stur, Karoline ;
Karlhofer, Franz M. ;
Stingl, Georg .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 (04) :802-807
[54]   Induction of Regulatory T Cells by Infliximab in Behcet's Disease [J].
Sugita, Sunao ;
Yamada, Yukiko ;
Kaneko, Satoshi ;
Horie, Shintaro ;
Mochizuki, Manabu .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2011, 52 (01) :476-484
[55]   A human skin explant model for predicting graft-versus-host disease following bone marrow transplantation [J].
Sviland, L ;
Dickinson, AM .
JOURNAL OF CLINICAL PATHOLOGY, 1999, 52 (12) :910-913
[56]  
Takahashi C, 1999, J IMMUNOL, V162, P5037
[57]   Defective Regulatory T Cells In Patients with Severe Drug Eruptions: Timing of the Dysfunction Is Associated with the Pathological Phenotype and Outcome [J].
Takahashi, Ryo ;
Kano, Yoko ;
Yamazaki, Yoshimi ;
Kimishima, Momoko ;
Mizukawa, Yoshiko ;
Shiohara, Tetsuo .
JOURNAL OF IMMUNOLOGY, 2009, 182 (12) :8071-8079
[58]   CD14(low)CD16(high): A cytokine-producing monocyte subset which expands during human immunodeficiency virus infection [J].
Thieblemont, N ;
Weiss, L ;
Sadeghi, HM ;
Estcourt, C ;
HaeffnerCavaillon, N .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (12) :3418-3424
[59]   A marked increase in serum soluble Fas ligand in drug-induced hypersensitivity syndrome [J].
Tohyama, M. ;
Shirakata, Y. ;
Sayama, K. ;
Hashimoto, K. .
BRITISH JOURNAL OF DERMATOLOGY, 2008, 159 (04) :981-984
[60]   Possible involvement of CD14+ CD16+ monocyte lineage cells in the epidermal damage of Stevens-Johnson syndrome and toxic epidermal necrolysis [J].
Tohyama, M. ;
Watanabe, H. ;
Murakami, S. ;
Shirakata, Y. ;
Sayama, K. ;
Iijima, M. ;
Hashimoto, K. .
BRITISH JOURNAL OF DERMATOLOGY, 2012, 166 (02) :322-330